Suicidal Ideation, Suicide Attempts, and Suicide Deaths in Adolescents and Young Adults With Type 1 Diabetes: A Systematic Review and Meta-analysis.


Journal

Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975

Informations de publication

Date de publication:
01 Jul 2024
Historique:
received: 27 02 2024
accepted: 13 04 2024
medline: 20 6 2024
pubmed: 20 6 2024
entrez: 20 6 2024
Statut: ppublish

Résumé

Evidence is lacking on the risk of suicide-related behaviors (suicidal ideation, suicide attempt, suicide death) in youth with type 1 diabetes (T1D). We aimed to 1) determine the prevalence of suicidal ideation, suicide attempts, and suicide deaths in adolescents and young adults (AYA) with T1D aged 10-24 years; 2) compare suicide-related behavior prevalence in youth with and without T1D; and 3) identify factors associated with suicide-related behaviors. A systematic search was conducted in MEDLINE, Embase, and PsycInfo up to 3 September 2023. We included observational studies where investigators reported the prevalence of suicide-related behaviors among AYA aged 10-24 years with T1D. We collected data on study characteristics, data on prevalence of suicide-related behaviors, and data on associated factors. We included 31 studies. In AYA with versus without T1D, pooled prevalence of suicidal ideation was 15.4% (95% CI 10.0-21.7; n = 18 studies) vs. 11.5% (0.4-33.3; n = 4), respectively, and suicide attempts 3.5% (1.3-6.7; n = 8) vs. 2.0% (0.0-6.4; n = 5). Prevalence of suicide deaths ranged from 0.04% to 4.4% among youth with T1D. Difficulties with T1D self-management were frequently reported to be associated with higher rates of suicide-related behaviors. However, findings on the association of glycemic levels and suicide-related behaviors were inconsistent. There was a considerable level of heterogeneity in meta-analysis of both suicidal ideation and suicide attempts. Suicidal ideation and suicide attempts are prevalent in AYA with T1D. Current evidence does not suggest that these rates are higher among AYA with T1D than rates among those without.

Sections du résumé

BACKGROUND BACKGROUND
Evidence is lacking on the risk of suicide-related behaviors (suicidal ideation, suicide attempt, suicide death) in youth with type 1 diabetes (T1D).
PURPOSE OBJECTIVE
We aimed to 1) determine the prevalence of suicidal ideation, suicide attempts, and suicide deaths in adolescents and young adults (AYA) with T1D aged 10-24 years; 2) compare suicide-related behavior prevalence in youth with and without T1D; and 3) identify factors associated with suicide-related behaviors.
DATA SOURCES METHODS
A systematic search was conducted in MEDLINE, Embase, and PsycInfo up to 3 September 2023.
STUDY SELECTION METHODS
We included observational studies where investigators reported the prevalence of suicide-related behaviors among AYA aged 10-24 years with T1D.
DATA EXTRACTION METHODS
We collected data on study characteristics, data on prevalence of suicide-related behaviors, and data on associated factors.
DATA SYNTHESIS RESULTS
We included 31 studies. In AYA with versus without T1D, pooled prevalence of suicidal ideation was 15.4% (95% CI 10.0-21.7; n = 18 studies) vs. 11.5% (0.4-33.3; n = 4), respectively, and suicide attempts 3.5% (1.3-6.7; n = 8) vs. 2.0% (0.0-6.4; n = 5). Prevalence of suicide deaths ranged from 0.04% to 4.4% among youth with T1D. Difficulties with T1D self-management were frequently reported to be associated with higher rates of suicide-related behaviors. However, findings on the association of glycemic levels and suicide-related behaviors were inconsistent.
LIMITATIONS CONCLUSIONS
There was a considerable level of heterogeneity in meta-analysis of both suicidal ideation and suicide attempts.
CONCLUSIONS CONCLUSIONS
Suicidal ideation and suicide attempts are prevalent in AYA with T1D. Current evidence does not suggest that these rates are higher among AYA with T1D than rates among those without.

Identifiants

pubmed: 38900947
pii: 156867
doi: 10.2337/dc24-0411
doi:

Types de publication

Journal Article Systematic Review Meta-Analysis Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1227-1237

Informations de copyright

© 2024 by the American Diabetes Association.

Auteurs

Olivier Renaud-Charest (O)

Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.

Alexander Stoljar Gold (A)

Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.

Elise Mok (E)

Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.

Jessica Kichler (J)

Department of Psychology, University of Windsor, Windsor, Ontario, Canada.

Meranda Nakhla (M)

Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
Division of Endocrinology, Department of Pediatrics, McGill University Health Centre, Montreal, Quebec, Canada.

Patricia Li (P)

Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
Division of General Pediatrics, Department of Pediatrics, McGill University Health Centre, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH